Institutional investors purchased a net $187.3 thousand shares of BCR during the quarter ended September 2015 and now own 91.39% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALYESKA INVESTMENT GROUP LP Bought 537.3 Thousand shares of C R Bard Inc
PYRAMIS GLOBAL ADVISORS LLC Bought 458.0 Thousand shares of C R Bard Inc
VONTOBEL ASSET MANAGEMENT, INC. Bought 430.1 Thousand shares of C R Bard Inc